L-Carnitine and Its Derivatives in Metabolic and Chronic Diseases: A Narrative Review
DOI:
https://doi.org/10.12775/QS.2026.67.74222Keywords
L-carnitine, acetyl-L-carnitine, cardiovascular disease, diabetes mellitus, obesity, dyslipidemia, neuropathy, polycystic ovary syndrome, male infertilityAbstract
Background. L-carnitine (LC) is a vitamin-like compound involved in mitochondrial fatty acid transport and energy metabolism. In addition to its physiological role, LC exhibits antioxidant and anti-inflammatory properties.
Aim. To summarize current evidence on the clinical applications, therapeutic potential, and safety of L-carnitine in human diseases.
Methods. A narrative review of systematic reviews, meta-analyses, and randomized controlled trials published between 2013 and 2025 was conducted using PubMed, Cochrane Library, and Google Scholar. Twenty-nine eligible studies were included.
Results. Current evidence indicates that L-carnitine may improve glucose metabolism, insulin sensitivity, lipid profile, neuropathic symptoms, and sperm quality. The strongest evidence supports benefits in metabolic disorders and male reproductive health, whereas evidence for major cardiovascular and reproductive outcomes remains limited. L-carnitine is generally well tolerated at doses up to 2–3 g/day, although prolonged supplementation may increase trimethylamine-N-oxide (TMAO) levels, with uncertain clinical significance.
Conclusion. L-carnitine appears to be a promising adjunctive nutritional intervention for selected patient populations. However, additional high-quality randomized controlled trials with long-term follow-up are needed to confirm its efficacy and safety.
References
[1] Virmani MA, Cirulli M. The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation. Int J Mol Sci. 2022;23(5):2717. Published 2022 Feb 28. doi:10.3390/ijms23052717
[2] Almannai M, Alfadhel M, El-Hattab AW. Carnitine Inborn Errors of Metabolism. Molecules. 2019;24(18):3251. Published 2019 Sep 6. doi:10.3390/molecules24183251
[3] Hanai T, Shiraki M, Imai K, Suetugu A, Takai K, Shimizu M. Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis. Nutrients. 2020;12(7):1915. Published 2020 Jun 29. doi:10.3390/nu12071915
[4] Alhasaniah AH. l-carnitine: Nutrition, pathology, and health benefits. Saudi J Biol Sci. 2023;30(2):103555. doi:10.1016/j.sjbs.2022.103555
[5] Bene J, Hadzsiev K, Melegh B. Role of carnitine and its derivatives in the development and management of type 2 diabetes. Nutr Diabetes. 2018;8(1):8. Published 2018 Mar 7. doi:10.1038/s41387-018-0017-1
[6] Mirrafiei A, Jayedi A, Shab-Bidar S. The Effects of L-Carnitine Supplementation on Weight Loss, Glycemic Control, and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Systematic Review and Dose-response Meta-Analysis of Randomized Controlled Trials. Clin Ther. 2024;46(5):404-410. doi:10.1016/j.clinthera.2024.03.002
[7] Rolim LC, da Silva EM, Flumignan RL, Abreu MM, Dib SA. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2019;6(6):CD011265. Published 2019 Jun 15. doi:10.1002/14651858.CD011265.pub2
[8] Li S, Li Q, Li Y, Li L, Tian H, Sun X. Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015;10(3):e0119479. Published 2015 Mar 9. doi:10.1371/journal.pone.0119479
[9] Hamedi-Kalajahi F, Zarezadeh M, Malekahmadi M, et al. The Effect of the L-Carnitine Supplementation on Obesity Indices: An Umbrella Meta-Analysis. Int J Vitam Nutr Res. 2025;95(2):40033. doi:10.31083/IJVNR40033
[10] Weng Y, Zhang S, Huang W, Xie X, Ma Z, Fan Q. Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2021;2021:9491615. Published 2021 Jan 12. doi:10.1155/2021/9491615
[11] Bruls YM, de Ligt M, Lindeboom L, et al. Carnitine supplementation improves metabolic flexibility and skeletal muscle acetylcarnitine formation in volunteers with impaired glucose tolerance: A randomised controlled trial. EBioMedicine. 2019;49:318-330. doi:10.1016/j.ebiom.2019.10.017
[12] Serban MC, Sahebkar A, Mikhailidis DP, et al. Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials. Sci Rep. 2016;6:19188. Published 2016 Jan 12. doi:10.1038/srep19188
[13] Lee BJ, Lin JS, Lin YC, Lin PT. Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease. Lipids Health Dis. 2016;15:107. Published 2016 Jun 17. doi:10.1186/s12944-016-0277-5
[14] Choi M, Park S, Lee M. L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2020;12(9):2795. Published 2020 Sep 12. doi:10.3390/nu12092795
[15] Alesi S, Ee C, Moran LJ, Rao V, Mousa A. Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome. Adv Nutr. 2022;13(4):1243-1266. doi:10.1093/advances/nmab141
[16] Gong Y, Jiang T, He H, et al. Effects of carnitine on glucose and lipid metabolic profiles and fertility outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2023;98(5):682-691. doi:10.1111/cen.14885
[17]Mohd Shukri MF, Norhayati MN, Badrin S, Abdul Kadir A. Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis. PeerJ. 2022;10:e13992. Published 2022 Sep 16. doi:10.7717/peerj.13992 .
[18] Fallah F, Mahdavi R. Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial. Front Endocrinol (Lausanne). 2023;14:1237882. Published 2023 Oct 18. doi:10.3389/fendo.2023.1237882
[19] Hafezi M, Arabipoor A, Ghaffari F, Vesali S, Zareei M, Hessari ZH. Adding L-carnitine to antagonist ovarian stimulation doesn't improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: a double-blind randomized clinical trial. J Ovarian Res. 2024;17(1):9. Published 2024 Jan 9. doi:10.1186/s13048-023-01319-7
[20] Khaw SC, Wong ZZ, Anderson R, Martins da Silva S. l-carnitine and l-acetylcarnitine supplementation for idiopathic male infertility. Reprod Fertil. 2020;1(1):67-81. Published 2020 Dec 23. doi:10.1530/RAF-20-0037
[21] Wei G, Zhou Z, Cui Y, et al. A Meta-Analysis of the Efficacy of L-Carnitine/L-Acetyl-Carnitine or N-Acetyl-Cysteine in Men With Idiopathic Asthenozoospermia. Am J Mens Health. 2021;15(2):15579883211011371. doi:10.1177/15579883211011371
[22] Ma L, Sun Y. Comparison of L-Carnitine vs. Coq10 and Vitamin E for idiopathic male infertility: a randomized controlled trial. Eur Rev Med Pharmacol Sci. 2022;26(13):4698-4704. doi:10.26355/eurrev_202207_29194
[23] Huijben M, Huijsmans RLN, Lock MTWT, de Kemp VF, de Kort LMO, van Breda JHMK. Clomiphene citrate for male infertility: A systematic review and meta-analysis. Andrology. 2023;11(6):987-996. doi:10.1111/andr.13388
[24] Micic S, Lalic N, Djordjevic D, et al. Double-blind, randomised, placebo-controlled trial on the effect of L-carnitine and L-acetylcarnitine on sperm parameters in men with idiopathic oligoasthenozoospermia. Andrologia. 2019;51(6):e13267. doi:10.1111/and.13267
[25] Song X, Qu H, Yang Z, Rong J, Cai W, Zhou H. Efficacy and Safety of L-Carnitine Treatment for Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2017;2017:6274854. doi:10.1155/2017/6274854
[26] Cruz WMS, Guimarães SMS, Maciel GC, et al. L-carnitine supplementation in the recovery of plasma L-carnitine in patients with heart failure submitted to coronary artery bypass grafting. An Acad Bras Cienc. 2018;90(3):3099-3104. doi:10.1590/0001-3765201820170352
[27] Sugiyama M, Hazama T, Nakano K, et al. Effects of Reducing L-Carnitine Supplementation on Carnitine Kinetics and Cardiac Function in Hemodialysis Patients: A Multicenter, Single-Blind, Placebo-Controlled, Randomized Clinical Trial. Nutrients. 2021;13(6):1900. Published 2021 May 31. doi:10.3390/nu13061900
[28] Xu Y, Jiang W, Chen G, et al. L-carnitine treatment of insulin resistance: A systematic review and meta-analysis. Adv Clin Exp Med. 2017;26(2):333-338. doi:10.17219/acem/61609
[29] Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576-585. doi:10.1038/nm.3145
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Weronika Zając, Jan Wandzel, Zofia Wandzel, Kamil Kunecki, Aleksander Urbaś, Miłosz Plichta, Rozalia Plichta, Emil Plichta, Katarzyna Wilk, Paulina Wietrzycka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 12
Number of citations: 0
